Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-01-24 10:01 am Purchase | 2021-12-31 | 13G | Vera Therapeutics, Inc. VERA | Ares Trading S.A. | 1,913,501 8.990% | 1,913,501 (New Position) | Filing History |
| 2021-06-10 11:37 am Purchase | 2021-06-09 | 13G | Vera Therapeutics, Inc. VERA | FMR LLC | 3,071,896 15.229% | 3,071,896 (New Position) | Filing History |
| 2021-05-28 4:17 pm Purchase | 2021-05-18 | 13G | Vera Therapeutics, Inc. VERA | CITADEL ADVISORS LLC | 2,025,050 9.900% | 2,025,050 (New Position) | Filing History |
| 2021-05-27 4:32 pm Purchase | 2021-05-18 | 13D | Vera Therapeutics, Inc. VERA | Longitude Capital Partners IV LLC | 3,096,594 15.100% | 3,096,594 (New Position) | Filing History |
| 2021-05-24 1:46 pm Purchase | 2021-05-18 | 13D | Vera Therapeutics, Inc. VERA | Sofinnova Venture Partners X L.P. | 2,914,776 14.500% | 2,914,776 (New Position) | Filing History |
| 2021-05-24 09:34 am Purchase | 2021-05-18 | 13D | Vera Therapeutics, Inc. VERA | Abingworth LLP | 2,960,231 14.600% | 2,960,231 (New Position) | Filing History |